EVALUATION OF MEMBRANOUS NEPHROPATHY DIAGNOSTIC AND MANAGEMENT APPROACH

被引:0
|
作者
Bokheder, Mojtaba Ali [1 ]
Asiri, Bander Bin Saleh Alsalmy [2 ]
Alsarah, Aouss Khalid Asad [2 ]
Alshahrani, Nawaf Abdullah [2 ]
Tarish, Saad Mohammed Al [2 ]
Harakati, Amal Maher [3 ]
Almuntashiri, Ibtisam Aziz A. [3 ]
Alamir, Feras Ahmed [4 ]
Alshmri, Shumukh Mohammed [5 ]
Alkhaldi, Ghadah Nashmi [6 ]
机构
[1] Omran Gen Hosp, Dept Med, Al Hasa, Saudi Arabia
[2] King Khalid Univ, Fac Med, Abha, Saudi Arabia
[3] King Abdulaziz Univ, Fac Med, Jeddah, Saudi Arabia
[4] Warsaw Med Univ, Fac Med, Warsaw, Poland
[5] Gurayat Gen Hosp, Dept Intens Care, Gurayat, Saudi Arabia
[6] Secur Forces Hosp, Dept Internal Med, Dammam, Saudi Arabia
来源
PHARMACOPHORE | 2021年 / 12卷 / 04期
关键词
Membranous nephropathy; Phospholipase A2 receptor; Systemic lupus erythematosus; Immunohistology; RECEPTOR ANTIBODY; HEYMANN NEPHRITIS; GLOMERULONEPHRITIS; THERAPY; DISEASE; IMMUNOPATHOGENESIS; PATHOMECHANISMS; COMPLEX; ANTIGEN;
D O I
10.51847/qixenY6Ym6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Membranous nephropathy is one of the most common causes of nondiabetic adults' nephrotic syndrome. It accounts for up to 30% of nephrotic syndrome cases in Caucasian adults. It can manifest as a primary or secondary disease, but primary is considered more common. The disease has a waxing and waning clinical course and indolent progress, and immunosuppressive treatment is deemed the mainstay therapy for promoting remission. Although there has been advancement in understanding the pathogenesis of this disease, it still requires further research. We aimed to review the literature to promote the understanding of membranous nephropathy. We reviewed the literature for membranous nephropathy; pathogenesis, etiology, clinical presentation, diagnosis, and treatment. Articles were chosen from the PubMed database, and selected studies were subjected to a thorough review. Membranous nephropathy is one of the most common causes of nephrotic syndrome in nondiabetic adults. The clinical course of this disease is waxing and waning and has indolent progression. Despite the improvement in diagnostic approaches and treatment options, it remains an active field for diagnostic and pharmacological research. Copyright (C) 2013 - All Rights Reserved - Pharmacophore
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [41] MEMBRANOUS NEPHROPATHY
    TURNER, DR
    JOURNAL OF PATHOLOGY, 1972, 106 (01): : PR7 - &
  • [42] Membranous nephropathy in the older adult - Epidemiology, diagnosis and management
    Deegens, Jeroen K. J.
    Wetzels, Jack F. M.
    DRUGS & AGING, 2007, 24 (09) : 717 - 732
  • [43] Membranous nephropathy
    Hoxha, E.
    Huber, T. B.
    NEPHROLOGE, 2020, 15 (06): : 343 - 346
  • [44] Membranous nephropathy
    Scheidat, S
    Stahl, RAK
    INTERNIST, 2003, 44 (09): : 1120 - 1130
  • [45] Membranous Nephropathy
    Cybulsky, Andrey V.
    EXPERIMENTAL MODELS FOR RENAL DISEASES: PATHOGENESIS AND DIAGNOSIS, 2011, 169 : 107 - 125
  • [46] Membranous nephropathy
    Ronco, Pierre
    Beck, Laurence
    Debiec, Hanna
    Fervenza, Fernando C.
    Hou, Fan Fan
    Jha, Vivekanand
    Sethi, Sanjeev
    Tong, Allison
    Vivarelli, Marina
    Wetzels, Jack
    NATURE REVIEWS DISEASE PRIMERS, 2021, 7 (01)
  • [47] Membranous nephropathy
    Pierre Ronco
    Laurence Beck
    Hanna Debiec
    Fernando C. Fervenza
    Fan Fan Hou
    Vivekanand Jha
    Sanjeev Sethi
    Allison Tong
    Marina Vivarelli
    Jack Wetzels
    Nature Reviews Disease Primers, 7
  • [48] Membranous nephropathy
    Hoxha, Elion
    Huber, Tobias B.
    NEPHROLOGIE, 2025, 20 (01): : 12 - 17
  • [49] Membranous nephropathy
    Dantas, Marcio
    Silva, Lazaro Bruno Borges
    Pontes, Barbhara Thais Maciel
    dos Reis, Marlene Antonia
    de Lima, Patricia Soares Nunes
    Neto, Miguel Moyses
    JORNAL BRASILEIRO DE NEFROLOGIA, 2023, 45 (02): : 229 - 243
  • [50] Membranous nephropathy
    Mercadal, Lucile
    NEPHROLOGIE & THERAPEUTIQUE, 2013, 9 (07): : 507 - 517